You are here

VX-135

Vertex: Risk-Reward Less Favorable If HCV Pipeline Is In Question

Seeking Alpha

Mon, 07/29/13 - 01:34 pm

Vertex Pharmaceuticals

Vertex Says U.S. Places Partial Hold on Hepatitis Study

Bloomberg

Sat, 07/27/13 - 11:09 am

Vertex Pharmaceuticals

Vertex Says U.S. Places Partial Hold on Hepatitis Study

Bloomberg

Thu, 07/25/13 - 05:27 pm

Vertex Pharmaceuticals

Vertex, Bristol-Myers enter agreement for Phase 2 studies of VX-135, daclatasvir

Yahoo/Fly on the Wall

Fri, 04/5/13 - 10:25 am

Vertex Pharmaceuticals

Bristol-Myers Squibb

Medivir Rises on Plans for Hepatitis C Study: Stockholm Mover

Bloomberg

Thu, 11/1/12 - 11:49 am

Vertex Pharmaceuticals

Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C

The Fly on the Wall

Thu, 11/1/12 - 10:05 am

Vertex Draws Collaboration Interest For Hepatitis C Combo

Bloomberg

Fri, 10/19/12 - 11:01 am

Vertex Pharmaceuticals